Literature DB >> 11953721

Emergence of new pathogens in CF: the devil we know or the devil we don't know?

Jane L Burns.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11953721     DOI： 10.1067/mpd.2002.123625

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  2 in total

1.  Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.

Authors:  Timothy J Kidd; Kay A Ramsay; Honghua Hu; Peter T P Bye; Mark R Elkins; Keith Grimwood; Colin Harbour; Guy B Marks; Michael D Nissen; Philip J Robinson; Barbara R Rose; Theo P Sloots; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

2.  In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.

Authors:  Paula King; Olga Lomovskaya; David C Griffith; Jane L Burns; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.